Exchange: OTC·Updated 09:30 AM EDT
About YPHDF
Ypsomed Holding AG engages in the development and manufacture of self-injection systems and drug delivery devices for pharmaceutical and biotechnology companies. It operates through the following segment: Delivery Systems. The Delivery Systems segment consists of pen injectors, autoinjectors, and wearable on-body devices, including UnoPen, ServoPen, YpsoPen, FixPen, YpsoMate, YpsoLoop, YpsoDose, LyoTwist, and VarioJect. The company was founded by Wilhelm Michel on December 29, 2003 and is headquartered in Burgdorf, Switzerland.